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Abstract 
Age-related frailty is characterized by increased vulnerability to stress due to decline in homeostatic reserve, which 
results in increased risk of adverse health outcomes including disability, hospitalization, and death. The relationship 
between frailty and immunological system alterations is well established. Thus, analysis of immunological changes, 
such as alterations in lymphocyte subsets, during senescence may provide useful markers for frailty and associated 
pathologies. Since reference ranges currently used for lymphocyte subsets do not specifically differentiate the elderly 
group, the aim of this study was to (1) establish reference ranges in nonfrail elderly individuals and (2) assess the 
evolution of these parameters with age. Further, the influence of other physiological and lifestyle factors was also 
evaluated. The study was performed on 144 elderly individuals (aged 65–95) from Galicia (in northwestern Spain). 
Percentages of lymphocyte subpopulations (CD3+ T lymphocytes, CD4+ T-helper lymphocytes, CD8+ T-cytotoxic 
lymphocytes, CD19+ B lymphocytes, and CD56+16+ natural killer cells) were analyzed in peripheral blood by flow 
cytometry, and reference ranges were calculated. The individual status as nonfrail or prefrail did not markedly affect 
the immunological parameters, but an apparent influence of age was obtained for %CD3+, %CD4+, and %CD19+ 
cells, all of which fell with increasing age. Women showed higher levels of %CD19+ lymphocytes. No significant 
influence of smoking habits, physical activity, or drinking alcohol or caffeine beverages was observed. The results 
obtained may serve as a basis to establish comparisons between frail and nonfrail elderly individuals, in order to 
determine the usefulness of lymphocyte subsets as immunological biomarkers of frailty. 
As a consequence of a decreasing mortality rate and declining fertility, populations in nearly all the 
countries in the world are aging. The “World Population Aging 2013” report from the United Nations 
(2013) warned that the population age group of 85 years and over is the most rapidly expanding, and its 
size is expected to double over the next 20 years. Consequently, by 2050, the number of elderly people 
globally will exceed the number of young individuals for the first time in history. This rise in the elderly 
population, along with the associated social and economic implications, has increased the interest in the 
study of aging processes and age-related conditions (Pizza et al., 2011). 
Chronological age is only an approximate indicator of aging and risk of age-related diseases, since 
extensive interindividual heterogeneity exists in the main outcomes of aging. In this context, the concept 
of “frailty” emerged as a new and more accurate measure of biological age (Bortz, 2002; Topinkova, 
2008). Thus, identification of frail elderly subjects is currently far more suitable to determine aging and 
development of age-related diseases (Pathai et al., 2013). 
Frailty is an important medical syndrome that represents a risk factor for those over 65 years of age. 
Frailty prevalence increases with age (Shamliyan et al., 2013), representing a growing challenge for 
societies worldwide. Although several clinical definitions and measures of frailty emerged in the last 
decades (Bouillon et al., 2013; Ensrud et al., 2009; Rockwood et al., 2007; Shamliyan et al., 2013), it was 
not until recently that a group of international experts reached a consensus clinical definition for frailty. 
Accordingly, frailty is a clinical state with multiple causes and contributors, characterized by an increase 
in an individual’s vulnerability for developing enhanced dependency and/or mortality when exposed to a 
stressor (Morley et al., 2013). The expert panel also pointed out the importance of screening for frail 
elderly greater than 70 years of age, since it might potentially be prevented and/or treated, and reverted in 
its early stages. 
Currently, frailty identification is based on clinical features; the phenotype criteria proposed by Fried 
et al. (2001) is one of the most commonly used. This assessment considers that an individual is frail when 
three or more of the following criteria are present: (i) shrinking or unintentional weight loss; (ii) muscular 
weakness; (iii) self-reported exhaustion; (iv) slow walk; and (v) low physical activity level (Fried et al., 
2001). 
However, the use of molecular and cellular biomarkers has a great potential of anticipating, at 
preclinical stages, the recognition of frail individuals and improving outcomes by means of prevention 
and intervention programs. Several investigators noted an association between frailty and immunological 
system alterations, including inmunosenescence and inflammation markers (Collerton et al., 2012). 
Analysis of immunological changes, such as alterations in lymphocyte subsets, during senescence may 
provide useful markers for frailty and associated pathologies. 
Flow cytometry has several advantages: (1) It is a precise and reliable technique for the assessment of 
immunological status (Al-Mawali et al., 2013); (2) a small quantity of biological sample is required; and 
(3) time needed for the analysis is very short, which is a great benefit in population studies due the vast 
amount of samples handled. 
Since reference ranges currently used for lymphocyte subsets are referred to adult individuals in 
general, without specifically differentiating the elderly group, the aims of this study were to (1) establish 
reference ranges of lymphocyte subsets (CD3
+
 T lymphocytes, CD4
+
 T-helper lymphocytes, CD8
+
 T-
cytotoxic lymphocytes, CD19
+
 B lymphocytes, and CD56
+
16
+
 natural killer [NK] cells) in nonfrail 
elderly individuals (aged 65 years and over), and (2) assess the evolution of these parameters with age. 
The influence of other physiological and lifestyle factors—namely, number of positive frailty items, 
gender, smoking habits, physical exercise, and consumption of alcohol or caffeine beverages—on the 
lymphocyte subpopulations was also evaluated. 
Materials and methods 
Subjects and Sample Collection 
In total, 144 adult volunteer donors, aged at least 65 years of age, were recruited for this study from 
several associations of retired or elderly people located in Galicia (in northwestern Spain). Participants 
were community subjects living at their home. Participants were individually assessed at the centers. All 
donors completed a questionnaire to assess demographic, lifestyle, and medical information. Qualified 
staff members with extensive experience in the gerontology field participated in the research for the 
clinical evaluation and were trained to unify criteria. Participants were excluded if they did not possess 
the necessary skills to be assessed. Exclusion criteria included taking medications known to affect the 
immune system and having any chronic infection including human immunodeficiency virus (HIV), 
hepatitis C virus (HCV), and hepatitis B virus (HBV). Frailty status of each participant was determined 
according to five criteria proposed by Fried et al. (2001). In brief, these criteria are (i) unintentional 
weight loss (i.e., not due to dieting or exercise): at least 4.5 kg in past year, (ii) self-reported exhaustion: 
identified by two questions from the modified 10-item Center for Epidemiological Studies-Depression 
(CES-D) scale, (iii) weakness: grip strength in the lowest 20% at baseline, adjusted for gender and body 
mass index, (iv) slow walking speed: the slowest 20% at baseline, based on time to walk 15 ft, adjusting 
for gender and standing height, and (v) low physical activity: the lowest 20% at baseline, based on a 
weighted score of kilocalories expended per week, calculated according to the Spanish validation of the 
Minnesota Leisure Time Activity (MLTA) questionnaire (Ruiz Comellas et al., 2012), according to each 
participant’s report, and adjusting for gender. Three or more of these criteria need to be present for an 
individual to be classified as frail; thus, a maximum of two positive criteria was considered the inclusion 
criterion for this study. Anatomical Therapeutic Chemical (ATC) classification was used to categorize 
drugs (WHO Collaborating Center for Drug Statistics Methodology, 2013). 
Whole blood was collected into EDTA Vacutainer tubes between 9:30 and 12:30 a.m., and transported 
to the lab immediately. Blood samples were stained and fixed within 4 h of collection. The study protocol 
was approved by the Ethics Committee at the University of A Coruña and conformed to the principles 
embodied in the Declaration of Helsinki. Before data collection, all individuals were informed about the 
study and signed the corresponding informed consent. 
Assessment of Lymphocyte Subsets 
Peripheral blood lymphocyte phenotypes were determined by three-color direct immunofluorescence 
surface marker analysis by flow cytometry. The following lymphocyte subsets were evaluated: T 
lymphocytes (CD3
+
), T-helper lymphocytes (CD3
+
 and CD4
+
), T-cytotoxic lymphocytes (CD3
+
 and 
CD8
+
), B lymphocytes (CD19
+
), and natural killer (NK) cells (CD3
−
 and CD16
+
56
+
). In brief, 100 μl 
whole peripheral blood was incubated for 15 min in the dark with the following antibodies (Immunostep), 
according to the manufacturer’s instructions: fluorescein isothiocyanate (FITC)-labeled antiCD3, 
phycoerythrin (PE)-labeled antiCD4, peridinin-chlorophyll-protein complex (PerCP)-labeled antiCD8, 
PerCP-labeled antiCD19, and PE-labeled antiCD16 and antiCD56. FACS lysing solution (Becton 
Dickinson) was then added and incubated for 8 min in the dark to remove erythrocytes by lysis. After 
washing with phosphate buffer solution (PBS), cells were fixed with CellFix (Becton Dickinson), and 
analyzed in a FACScalibur flow cytometer using Cell Quest Pro software (Becton Dickinson). 
Lymphocytes were gated on the basis of forward/side scatter plots, and fluorescence data from FL1 
(FITC), FL2 (PE), and FL3 (PerCP) were obtained to determine percentages of different lymphocyte 
subsets. At least 10
4
 events in the lymphocytes window were acquired. 
All specimens were analyzed using identical reagents, instruments, and procedures. All measurements 
were analyzed and interpreted by the same analyst following a standard procedure. Background staining 
was assessed using appropriate isotype controls (Immunostep). The flow cytometer was calibrated using 
fluorescent beads (CaliBrite) using FACSComp software (all from Becton Dickinson). 
Statistical Analysis 
Descriptive statistics (mean, median, standard deviation [SD], standard error [SE], 2.5th to 97.5th 
percentiles) for each percentage of lymphocytes subset were obtained using standard procedures. The 
assumption of a normal distribution for continuous variables was verified using the Kolmogorov–
Smirnov test. When normality was assumed according to the Kolmogorov–Smirnov test (%CD3+, 
%CD4
+
, and %CD16
+
56
+
), reference ranges were defined by the mean ± 2SD. When the hypothesis of 
normality for the quantitative variable was not accepted (%CD8
+
, CD4
+
/CD8
+
, and %CD19
+
), data were 
considered to have a non-Gaussian distribution, and reference ranges were defined as the central 95% of 
the area under the distribution curve of values (from 2.5 to 97.5%). 
To achieve a better approximation to the normal distribution, logarithmic transformation was applied 
to %CD8
+
 and %CD19
+
; CD4
+
/CD8
+
 rates were transformed to square root values. A preliminary 
comparison of the mean values between groups was performed with Student’s t-test for two groups 
(gender, physical activity, and alcohol and caffeine beverages consumption) or single-factor analysis of 
variance (ANOVA) for more than two groups (frailty positive items, age, and smoking). 
Linear regression using the natural logarithm (ln) of each subset was then used to test for differences 
between groups. All statistical models were adjusted for all parameters considered. Correlations between 
two variables were assessed using Pearson correlation. Values of p < .05 were considered significant. 
Data were analyzed using the IBM SPSS Statistics software, version 20, and STATA/SE 12.0 for 
Windows software. 
Results 
The characteristics of the study population are presented in Table 1. One hundred and forty-four 
donors aged 65 years and over (range from 65 to 95) were analyzed. More than half of the subjects (55%) 
were positive for one frailty item (prefrail—one item), the rate of female gender was largest (64%), 
distribution among 5 established age groups (grouped by 5 years until 84, and the last category included 
individuals older than 84 years) was quite equitable, and most subjects were nonsmokers, although there 
were 22% ex-smokers (who gave up smoking since 6 to 62 years ago). Positive answer to caffeine 
beverages consumption was obtained for 63% of subjects. Half of the individuals reported consuming 
alcoholic beverages, and the same rate expended less than 3,350 kcal/week in different physical activities. 
Table 2 shows drug consumption by the study subjects, classified according to their frailty status 
(nonfrail, prefrail—one item or prefrail—two items) and the main category of drugs. In general, the more 
positive frailty items there were, the higher was the drug consumption for all families. Especially 
remarkable is consumption of drugs for the cardiovascular system, alimentary tract, and metabolism, and 
anti-infectives for systemic use in all three groups of subjects, and consumption of drugs for the nervous 
system and musculoskeletal system in the two prefrail groups. Among all ATC system main groups, only 
drugs from the categories antiparasitic products, insecticides and repellents, and various were not 
consumed by any study subject.  
  
Table 1. Characteristics of the Study Population 
 
  
Number of individuals 144 
Frailty items 
 Nonfrail 37 (25.7%) 
 Prefrail—one item 79 (54.9%) 
 Prefrail—two items 28 (19.4%) 
Gender 
 Males 52 (36.1%) 
 Females 92 (63.9%) 
Smoking 
 Nonsmokers 107 (74.3%) 
 Smokers 5 (3.5%) 
  Pack-yearsa 26.4 ± 23.9 (6.6–66.0) 
 Ex-smokers 32 (22.2%) 
  Pack-yearsa 14.0 ± 10.4 (0.6–35.0) 
  Years since stop smokinga 29.2 ± 13.9 (6.0–62.0) 
Age (years)a 75.1 ± 6.7 (65–95) 
 65–69 38 (26.4%) 
 70–74 35 (24.3%) 
 75–79 31 (21.5%) 
 80–84 24 (16.7%) 
 ≥85 16 (11.1%) 
Alcohol consumption 
 No 74 (51.4%) 
 Yes 70 (48.6%) 
Caffeine beverages consumption 
 No 54 (37.5%) 
 Yes 90 (62.5%) 
 Physical activity (kcal/week)a,b 3861 ± 2629 (395–15178) 
 <3,350 71 (49.3%) 
 ≥3,350 73 (51.7%) 
  
 
a Mean ± SD (range). 
b Calculated according to Minnesota Leisure Time Activity (MLTA) questionnaire (Spanish validation by Ruiz Comellas et al., 
2012). 
  
Table 2. Number of Individuals Consuming Drugs, Classified According to the Main Group of Drugs (ATC Classification) 
Group of drugs Nonfrail Prefrail, one item Prefrail, two items 
    
Alimentary tract and metabolism 18 (48.6%) 41 (51.9%) 23 (82.1%) 
Blood and blood-forming organs 8 (21.6%) 21 (26.6%) 10 (35.7%) 
Cardiovascular system 18 (48.6%) 56 (70.9%) 20 (71.4%) 
Dermatologicals 9 (24.3%) 8 (10.1%) 6 (21.4%) 
Genitourinary system and sex hormones 5 (13.5%) 14 (17.7%) 2 (7.1%) 
Systemic hormonal preparations, excluding sex hormones and insulins 2 (5.4%) 1 (1.3%) 4 (14.3%) 
Antiinfectives for systemic use 20 (54.1%) 35 (44.3%) 15 (53.6%) 
Musculoskeletal system 4 (10.8%) 23 (29.1%) 12 (42.9%) 
Nervous system 7 (18.9%) 41 (51.9%) 22 (78.6%) 
Respiratory system 3 (8.1%) 9 (11.4%) 4 (14.3%) 
Sensory organs 9 (24.3%) 24 (30.4%) 11 (39.3%) 
    
 
Immunofluorescence surface marker analysis was performed by flow cytometry. The means, standard 
errors, medians, and reference ranges for the lymphocyte subsets studied in the whole population are 
collected in Table 3. Tables 4–10 show the effect of number of positive frailty items, age, gender, 
smoking habits, physical activity, alcohol consumption, and caffeine beverages consumption, 
respectively, on lymphocyte subsets, according to linear regression analyses where all these parameters 
were mutually adjusted. 
Table 3. Lymphocyte Subsets in the Whole Population 
  N Mean SE Median Reference range 
      
%CD3+ 144 71.70 0.85 72.03 51.24–92.16 
%CD4+ 144 42.06 0.93 43.57 19.80–64.32 
%CD8+ 144 23.88 0.92 21.59 8.28–54.17 
CD4+/CD8+ 144 2.31 0.13 2.01 0.46–6.57 
%CD19+ 144 7.62 0.38 6.80 1.94–20.15 
%CD16+56+ 144 18.77 0.76 17.98 0.61–36.93 
      
 
Note. SE: mean standard error. 
  
Table 4. Effect of Number of Positive Frailty Items on Lymphocyte Subsets 
  Non-frail 
 
Prefrail—one item 
 
Prefrail—two items 
Frailty Mean ± SE Mean ratio [95%CI] 
 
Mean ± SE Mean ratio [95%CI] 
 
Mean ± SE Mean ratio [95%CI] 
            
%CD3+ 71.61 ± 1.61 1.00 —  71.74 ± 1.12 0.99 [0.94–1.07]  71.68 ± 2.25 1.01 [0.93–1.10] 
%CD4+ 44.15 ± 1.79 1.00 —  42.31 ± 1.24 1.03 [0.76–1.41]  43.71 ± 2.25 1.24 [0.83–1.85] 
%CD8+ 23.07 ± 2.00 1.00 —  24.10 ± 1.20 1.12 [0.92–1.37]  24.33 ± 2.07 1.09 [0.85–1.40] 
CD4+/CD8+ 2.52 ± 0.27 1.00 —  2.22 ± 0.19 0.92 [0.64–1.33]  2.28 ± 0.27 1.14 [0.71–1.84] 
%CD19+ 7.85 ± 0.81 1.00 —  7.72 ± 0.56 0.86 [0.68–1.10]  7.02 ± 0.59 0.81 [0.59–1.10] 
%CD16+56+ 19.02 ± 1.50 1.00 —  18.73 ± 0.99 1.11 [0.87–1.42]  18.55 ± 1.89 1.13 [0.83–1.54] 
            
 
Note. CI: confidence interval, SE: mean standard error.
 Table 5. Effect of Age on Lymphocyte Subsets 
  65-69  70-74  75-79  80-84  ≥85 
Age group Mean ± SE Mean Ratio [95%CI]  Mean ± SE Mean ratio [95%CI]  Mean ± SE Mean ratio [95%CI]  Mean ± SE Mean ratio [95%CI]  Mean ± SE Mean ratio [95%CI] 
                    
%CD3+ 74.04 ± 1.45a 1.00 —  71.65 ± 1.23a 0.97 [0.90–1.04]  71.36 ± 1.38a 0.97 [0.90–1.05]  74.46 ± 2.24a 0.99 [0.92–1.08]  62.72 ± 4.06b 0.82* [0.74–0.90] 
%CD4+ 46.45 ± 1.53a 1.00 —  43.14 ± 1.22ab 0.97 [0.69–1.36]  44.43 ± 1.80ab 1.01 [0.71–1.44]  40.64 ± 3.44ab 0.57* [0.39–0.83]  35.80 ± 2.59b 0.72 [0.47–1.11] 
%CD8+ 23.31 ± 1.50 1.00 —  23.71 ± 1.63 1.00 [0.81–1.24]  20.91 ± 1.39 0.88 [0.71–1.11]  30.06 ± 3.29 1.19 [0.94–1.52]  22.11 ± 2.95 0.85 [0.64–1.12] 
CD4+/CD8+ 2.40 ± 0.22 1.00 —  2.28 ± 0.24 0.97 [0.65–1.45]  2.70 ± 0.40 1.14 [0.74–1.75]  1.83 ± 0.28 0.47* [0.30–0.75]  2.08 ± 0.34 0.85 [0.51–1.44] 
%CD19+ 8.22 ± 0.62ac 1.00 —  7.45 ± 0.64abc 0.82 [0.64–1.07]  6.27 ± 0.53bc 0.72* [0.55–0.95]  6.05 ± 0.71b 0.64* [0.47–0.85]  11.55 ± 2.14a 1.33 [0.95–1.86] 
%CD16+56+ 16.74 ± 1.34 1.00 —  20.07 ± 1.33 1.29 [0.99–1.68]  20.89 ± 1.67 1.25 [0.94–1.65]  16.27 ± 1.70 0.99 [0.74–1.35]  20.39±3.16 1.14 [0.81–1.61] 
                    
 
Note.CI: confidence interval, SE: mean standard error. Means with different superscript letters represent significantly different groups: a ≠ b ≠ c, p < .05 (univariate statistics). Asterisk, significant at p < .05 
Table 6. Effect of Gender on Lymphocyte Subsets 
  Females  Males 
Gender Mean ± SE Mean ratio [95%CI]  Mean ± SE Mean ratio [95%CI] 
        
%CD3+ 72.24 ± 0.92 1.00 —  70.72 ± 1.72 0.97 [0.90–1.03] 
%CD4+ 43.90 ± 1.13 1.00 —  41.56 ± 1.60 0.81 [0.59–1.10] 
%CD8+ 23.50 ± 1.16 1.00 —  24.55 ± 1.53 1.14 [0.94–1.38] 
CD4+/CD8+ 2.42 ± 0.18 1.00 —  2.11 ± 0.19 0.71 [0.49–1.03] 
%CD19+ 8.07 ± 0.43 1.00 —  6.82 ± 0.74 0.71* [0.56–0.90] 
%CD16+56+ 18.04 ± 0.90 1.00 —  20.06 ± 1.37 1.16 [0.91–1.48] 
        
 
Note. CI: confidence interval, SE: mean standard error. Asterisk indicates significant at p < .05 
Table 7. Effect of Smoking Habits on Lymphocyte Subsets 
  Nonsmoker  Smoker  Ex-smoker 
Smoking Mean ± SE Mean ratio [95%CI]  Mean±SE Mean ratio [95%CI]  Mean±SE Mean ratio [95%CI] 
            
%CD3+ 
71.62 ± 
0.91 
1.00 —  
74.68 ± 
5.72 
1.10 [0.95–1.28]  
71.47 ± 
2.21 
1.02 [0.95–1.09] 
%CD4+ 
42.84 ± 
1.04 
1.00 —  
40.30 ± 
6.05 
1.34 [0.66–2.69]  
44.22 ± 
2.18 
1.28 [0.92–1.77] 
%CD8+ 
23.60 ± 
1.06 
1.00 —  
30.28 ± 
6.20 
1.28 [0.82–1.99]  
23.81 ± 
1.95 
1.01 [0.82–1.25] 
CD4+/CD8+ 2.35 ± 0.16 1.00 —  1.57 ± 0.39 1.05 [0.45–2.41]  2.29 ± 0.25 1.26 [0.85–1.87] 
%CD19+ 7.54 ± 0.39 1.00 —  6.24 ± 0.66 1.12 [0.65–1.93]  8.11 ± 1.13 1.10 [0.85–1.41] 
%CD16+56+ 
18.82 ± 
0.87 
1.00 —  
16.05 ± 
4.75 
0.65 [0.37–1.12]  
19.04 ± 
1.64 
0.97 [0.75–1.25] 
            
 
Note. CI: confidence interval, SE: mean standard error. 
Table 8. Effect of Physical Activity on Lymphocyte Subsets 
  <3,350 kcal/wk  ≥3,350 kcal/wk 
Physical activity Mean ±SE Mean ratio [95%CI]  Mean ± SE Mean ratio [95%CI] 
        
%CD3+ 71.46 ± 1.14 1.00 —  71.92 ± 1.27 0.99 [0.95–1.05] 
%CD4+ 42.51 ± 1.26 1.00 —  43.59 ± 1.36 0.97 [0.76–1.24] 
%CD8+ 24.99 ± 1.44 1.00 —  22.80 ± 1.16 0.93 [0.79–1.09] 
CD4+/CD8+ 2.28 ± 0.21 1.00 —  2.34 ± 0.16 1.04 [0.78–1.40] 
%CD19+ 7.70 ± 0.48 1.00 —  7.54 ± 0.60 0.96 [0.79–1.16] 
%CD16+56+ 19.19 ± 1.10 1.00 —  18.36 ± 1.05 0.96 [0.79–1.16] 
        
 
Note. CI: confidence interval, SE: mean standard error. 
  
Table 9. Effect of Alcohol Consumption on Lymphocyte Subsets 
  Nonconsumers  Consumers 
Alcohol Mean ± SE Mean ratio [95%CI]  Mean ± SE Mean ratio [95%CI] 
        
%CD3+ 72.35 ± 1.21 1.00 —  71.01 ± 1.20 0.97 [0.92–1.03] 
%CD4+ 41.99 ± 1.26 1.00 —  44.18 ± 1.36 1.10 [0.85–1.42] 
%CD8+ 25.28 ± 1.39 1.00 —  22.40 ± 1.18 0.86 [0.73–1.01] 
CD4+/CD8+ 2.12 ± 0.15 1.00 —  2.51 ± 0.22 1.28 [0.94–1.74] 
%CD19+ 7.57 ± 0.46 1.00 —  7.67 ± 0.63 1.08 [0.88–1.32] 
%CD16+56+ 17.79 ± 1.14 1.00 —  19.80 ± 0.98 1.17 [0.96–1.43] 
        
 
Note. CI: confidence interval, SE: mean standard error. 
Table 10. Effect of Caffeine Beverages Consumption on Lymphocyte Subsets 
  Nonconsumers  Consumers 
Caffeine beverages Mean ± SE Mean ratio [95%CI]  Mean ± SE Mean ratio [95%CI] 
        
%CD3+ 71.92 ± 1.36 1.00 —  71.56 ± 1.10 0.99 [0.94–1.05] 
%CD4+ 44.46 ± 1.44 1.00 —  42.21 ± 1.20 0.84 [0.65–1.09] 
%CD8+ 23.78 ± 1.63 1.00 —  23.94 ± 1.11 1.04 [0.88–1.22] 
CD4+/CD8+ 2.57 ± 0.28 1.00 —  2.15 ± 0.13 0.81 [0.60–1.10] 
%CD19+ 7.41 ± 0.58 1.00 —  7.74 ± 0.51 1.11 [0.91–1.35] 
%CD16+56+ 18.52 ± 1.23 1.00 —  18.92 ± 0.96 0.98 [0.80–1.19] 
        
 
Note. CI: confidence interval, SE: mean standard error. 
No significant differences were observed for any of the parameters analyzed between nonfrail and 
prefrail subjects, regardless of the number of positive frailty items (1 or 2; Table 4). Among prefrail 
individuals positive for one frailty item, the great majority (n = 74 out of 79, 94%) were positive for the 
item indicative of muscle weakness. Similarly, all individuals positive for two frailty items (n = 28) were 
positive for the grip strength item, and also for slow walk (n = 19), self-reported exhaustion (n = 8), or 
unintentional weight loss (n = 1). 
As presented in Table 5, age presented influence on %CD3
+
, %CD4
+
, and %CD19
+
 cell 
subpopulations. A significant decrease in %CD3
+
 lymphocytes was found only in the group of individuals 
aged ≤85 years. Progressive decline with age was observed in %CD4+ cells, more pronounced from 80 
years old and higher, and significant for individuals aged 80–84 years. Indeed, inverse and significant 
correlations were obtained between age and these two parameters (r = –0.229, p < .01 for %CD3+ and r = 
–0.292, p < .01 for %CD4+). In addition, a significant reduction in CD4+/CD8+ ratio was detected in the 
group 80–84 years old. The levels of %CD19+ lymphocytes also diminished progressively with age. The 
reduction was significant in the groups of 75–79 years and 80- to 84-year-old subjects. However, the 
group of individuals aged ≤85 years showed a recovery in %CD19+ cells, and levels were not markedly 
different from lower age group levels. %CD19
+
 was the only lymphocyte subset found to be influenced 
by gender (Table 6), showing a significant fall in males. CD4
+
/CD8
+
 ratio was numerically higher in 
females than males, but not significant. 
With respect to alcohol consumption (Table 9), no significant change in %CD8
+
 was found in alcohol 
consumers compared to nonconsumers. As shown in Tables 7, 8, and 10, no marked differences were 
observed for any lymphocyte subset according to smoking habits (either establishing nonsmokers, 
smokers, and ex-smokers as separate categories or comparing nonsmokers with ever-smokers, i.e., by 
merging smokers and ex-smokers in the same category [data not shown]), physical activity or caffeine 
beverages consumption. 
Discussion 
The objective of this investigation was to establish reference value ranges of lymphocyte subsets in 
the nonfrail elderly and assess the influence of age on these immunological parameters. In addition, this 
study aimed to determine the effect of other possible physiological or lifestyle factors (namely, gender, 
smoking habits, physical activity, and alcohol and caffeine beverages consumption) on these variables. 
Given the advanced age of the study subjects, most of them consumed some drugs (Table 2). 
Although the number of positive frailty items was parallel to the rate of medicated individuals for all drug 
groups, drugs for the cardiovascular system, along with those for the alimentary tract and metabolism and 
anti-infectives for systemic use, were the most representative in both nonfrail and prefrail individuals. 
Frailty was described as a major consequence of sarcopenia, the age-related loss in muscle mass and 
strength (Roubenoff, 2000). 
At the clinical level, assessment of muscle mass and function has emerged as a possible biomarker for 
aging (Fisher, 2004), and sarcopenia was also reported to be associated with telomere shortening 
(Marzetti et al., 2014), another indicator of biological aging (Fossel, 2012). Muscle weakness was present 
in almost all our prefrail individuals; accordingly, their consumption of drugs for the musculoskeletal 
system was notably higher than in nonfrail individuals. The same occurred for drugs for the nervous 
system; among them, the most notable subgroups being analgesics (consumed by 17.8% of prefrail—one 
item subjects and by 39.3% of prefrail—two items subjects), anxiolytics (29.1 and 35.7%, respectively), 
and antidepressants (19 and 28.6%, respectively). Indeed, associations between frailty and sleep 
disturbances (Ensrud et al., 2012) or depression (Mezuk et al., 2012) were noted. It is possible that drug 
consumption may have influenced the results in the current study in some manner, but establishing these 
reference value ranges in the elderly is inevitably linked to medication use, and therefore our results are 
expected to be representative for the general elderly population. 
The distributions of lymphocyte subsets found in this study (Table 3) were quite different from those 
described by Vasson et al. (2013) for a Spanish population (range of differences between means from 
6.3% for %CD3
+
 lymphocytes to 74.5% for %CD19
+
 lymphocytes). These differences are probably 
related to the broader age range of the participants in that study (20–75 years), and also to the fact that it 
was restricted to men. To our knowledge, this is the first lymphocyte subpopulation study focused on the 
elderly sector of the population that takes into account their status regarding absence of frailty. Less 
pronounced differences were observed when our results were compared with values from other adult 
Spanish populations, although in general our population levels were usually lower (García-Dabrio et al., 
2012, age range 16–88 years; Andreu-Ballester et al., 2012, age range 18–95 years). 
Elderly subjects positive for one or two frailty items, classified as prefrail according to Fried et al. 
(2001), were not markedly different from nonfrail elderly individuals according to lymphocyte subsets 
analyzed (Table 4); hence, the presence of muscle weakness or slow walking does not appear to produce 
alterations in these immunological variables. Data suggest that nonfrail and prefrail individuals may be 
classified jointly in studies addressing immunological parameters in elderly people. 
The immune functions decline with increasing age. This phenomenon is known as 
immunosenescence, and is partially responsible for increased prevalence and severity of infectious 
diseases, increased autoimmunity, and low efficacy of vaccination in elderly persons (Mahbub et al., 
2011). It should be noted that elderly subjects spend 80–90% of their time indoors and predominantly at 
elder care centers (Viegas et al., 2014). Further, the potential for exposure to fungal and indoor air 
contaminants is enhanced in elder care centers (Mendes et al., 2013; Viegas et al., 2014). Thus increased 
exposure potential to pollutants and diminished ability to cope due to lack of immunocompetence 
indicates that the elderly subpopulation is at higher risk for adverse effects. Immunosenescence affects 
both adaptive (T and B lymphocytes) and innate (monocytes, NK cells, and dendritic cells) systems. 
However, the more severe age-related changes occur in the adaptive system and higher exposure potential 
to contaminants is a cause for concern. The innate system is apparently better preserved during the aging 
process (Weiskopf et al., 2009). 
Maturation of T lymphocytes occurs in the thymus. One of the most remarkable changes in 
immunosenescence is the involution of the thymus, and consequently a decrease in the proportion of T 
lymphocytes with age (Chinn et al., 2012; Goronzy and Weyand, 2005). Moreover the aging process in T 
lymphocytes may be accelerated by several factors, including repeated exposure to antigens, 
environmental chemicals, and pathogens like cytomegalovirus (CMV), herpes viruses, or polyomaviruses 
(Weiskopf et al., 2009). 
In the current study, the percentage of total T lymphocytes (%CD3
+
) remained stable in subjects aged 
between 65 and 84 years, and a significant decrease was observed in the eldest group (≥85 years) (Table 
5). In addition, %CD4
+
 lymphocytes experienced a progressive fall with age, more notable in the two 
eldest categories, and significance was obtained for the group 80–84 years old. Consequently, and despite 
no marked differences observed in %CD8
+
 cells, CD4
+
/CD8
+
 ratio also diminished significantly in the 
same group. Similar data were reported by Andreu-Ballester et al. (2012) and Bisset et al. (2004). 
However, other studies found opposite results. García-Dabrio et al. (2012) observed an age-related 
increase of %CD4
+
 cells, while Jentsch-Ullrich et al. (2005) noted an age-related reduction in %CD8
+
. No 
marked differences linked to age for any lymphocyte subset were observed by Santagostino et al. (1999). 
The wider age ranges and younger study populations analyzed in these studies may account for 
differences compared to our results. 
B-lymphocytes maturation occurs in the bone marrow. The aging process initiates changes within the 
bone marrow, leading to a defective production of B-lymphocyte progenitors (Chinn et al., 2012; Pritz et 
al., 2014). In addition, B-cell functions experience age-related alterations and, consequently, specificity 
and class of antibodies produced change with age. This entails a rise in susceptibility to infectious 
diseases and reduces the effectiveness of vaccination in the elderly (Frasca et al., 2011. Further, the 
proportions of mature human B lymphocytes significantly decrease with age (Frasca et al., 2011. 
Accordingly, the current results showed a progressive decline with age in the levels of %CD19
+
 
lymphocytes, reaching significance in the groups 75–79 and 80–84 years old (Table 5). These findings are 
in agreement with the results of Jentsch-Ullrich et al. (2005) in a German population, and García-Dabrio 
et al. (2012) and Vasson et al. (2013) in Spanish populations. Nevertheless, these later investigators did 
not find a change in subjects from France or Austria. They suggest that the Mediterranean diet (more 
frequent in Spain) may play a role in these results, and in the marked age-linked increase in percent of 
NK cells in the Spanish population, discussed in the following. 
NK cells are cytotoxic cells that play a crucial role as modulators of tumor, viral, and microbial 
immunogenicity (Mahbub et al., 2011). Aging is related to NK-cell alterations, both functional and 
phenotypically. NK senescent cells seem to present a defective functional capacity with advanced age that 
is partially compensated by elevating the number of mature NK cells. High levels of NK cells are 
associated with high NK cytotoxicity, and therefore an age-related increased proportion of NK cells is 
related to healthy aging and longevity (Weiskopf et al., 2009). Previous studies found age-related rise in 
%CD16
+
56
+
 in healthy volunteers, particularly for those aged over 50 (Jentsch-Ullrich et al., 2005) or 
over 60 (Vasson et al., 2013). Percentages of NK cells did not change markedly with age in our study. All 
individuals analyzed were over 64 years (until 95) and supposed to display healthy aging, since they were 
not frail. Hence, stability found in NK cell levels with age suggests that the increase in proportion of these 
cells may already have occurred some time ago. 
It is known that males and females deal differently with infections, and the prevalence of autoimmune 
diseases is different between genders. This is in part due to dissimilarities in the immune systems of men 
and women, since females produce more robust humoral and cellular immune responses than males. 
However, the reason for the gender-related differences in immunosenescence still requires investigation 
(Yan et al., 2010). 
Previous studies demonstrated differences between genders in percentages of immune cell subtypes 
(Jentsch-Ullrich et al., 2005; Yan et al. 2010). In our study, females showed a significantly higher 
%CD19
+
 cells (Table 6). These results are consistent with those of Abdullah et al. (2012), who similarly 
noted a higher percentage of B lymphocytes in females. No significant gender-related differences were 
found in the present study for T lymphocytes or NK cells, similar to previous studies (Shokouhi 
Shoormasti et al., 2011; Valiathan et al., 2014). Nevertheless, significantly higher %CD3
+
 and CD4
+
 cells 
and a lower % NK cells in women were also reported in Spanish (Andreu-Ballester et al., 2012; García-
Dabrio et al., 2012) and Italian (Santagostino et al., 1999) populations. Since only elderly individuals 
were examined in this investigation, our results suggest that gender differences detected in other studies 
decrease with age; indeed, female values obtained for %CD3
+
 and %CD4
+
 lymphocytes were numerically 
higher than in males, and for %CD16
+
56
+
 cells were numerically lower, but significance was not reached. 
The influence of smoking, physical activity, and alcohol and caffeine beverage consumption on 
lymphocyte subsets was also studied, but none of these factors demonstrated a significant effect. Previous 
studies found alterations in levels of different lymphocyte subsets in smokers compared to nonsmokers 
(Andreoli et al., 2014; García-Dabrio et al., 2012; Jubri et al., 2013; Santagostino et al., 1999). Touil et al. 
(2012) also reported no marked influence of smoking. The relevance of our negative results regarding 
smoking factor (Table 7) is only marginal, due to the small group of smokers analyzed (n = 5). Moreover, 
the number of ex-smokers was not high either (n = 32), and they ceased to smoke a minimum of 6 years 
ago, such that their physiological status resembles nonsmokers rather than smokers. 
Acute physical exercise was reported to produce transient variations in some lymphocyte subsets 
(Ceddia et al., 1999). Specifically, increases in CD8
+
 and CD4
+
 T cells were observed immediately post 
exercise (modified Balke maximal exercise treadmill test), but 20 min later only CD8
+
 cell level was still 
elevated. Long-term (2 years) moderate physical activity did not produce changes in the distribution of 
lymphocyte subpopulations in elderly women (62–86 years old) compared to a sedentary control group 
(Drela et al., 2004). Our negative results support these latter studies, since physical activity estimated 
referred to a regular month or week (from the Spanish validation of Minnesota Leisure Time Activity 
[MLTA] questionnaire [Ruiz Comellas et al., 2012]), and thus can be considered long-term. Drela et al. 
(2004) also observed a higher percentage of lymphocytes expressing intracellular interleukin 2, an 
important regulator of immune response, in the group of women attending the physical activity program, 
indicating that physical activity-mediated amelioration of immunosenescence occurs by mechanisms 
different from alterations in immune cell subpopulations. 
Regarding alcohol consumption, Matos et al. (2013) reported significantly lower percentages of T 
lymphocytes—both helper and cytotoxic—and B lymphocytes, but not NK cells, in patients with 
alcoholic liver disease compared to control cases. In the current study no marked differences between 
alcohol consumers and nonconsumers were observed in the proportions of lymphocyte subsets, except for 
a nonsignificant numerical decrease in %CD8
+
 cells. Still, consumption of alcoholic beverages by the 
study individuals was moderate: 59% of alcohol drinkers consumed 7 measures/week, and maximal 
reported was 14 measures/week (11%); wine was the preferred alcoholic beverage in nearly all cases 
(92%). To our knowledge, no apparent studies were found thus far on the effect of moderate alcohol 
consumption on lymphocyte subsets distribution in relatively healthy elderly individuals. 
Caffeine, a member of the methylxanthine family of drugs, is probably the behaviorally active 
substance most widely consumed in the Western countries due to its presence in common drinks like 
coffee, tea, and some soft drinks. Caffeine is known to modulate both innate and adaptive immune 
responses (Horrigan et al., 2006). Bishop et al. (2005) found significantly higher levels of %CD4
+
 and 
%CD8
+
 activated lymphocytes (expressing the CD69 surface antigen) 1 h postadministration in 
individuals at rest administered caffeine (6 mg/kg body mass) compared to placebo. In contrast, Fletcher 
and Bishop (2012) did not observe any marked differences in total count of CD4
+
 and CD8
+
 cells in 
individuals who ingested the same quantity of caffeine compared to the group administered placebo. 
Caffeine-related differences were also not found in lymphocyte subsets in our study. However, the Bishop 
et al. (2005) and Fletcher and Bishop (2012) studies were carried out with endurance-trained young males 
(less than 30 years old in both cases), a population clearly different from the current study population. 
Assuming that a cup of coffee (espresso, 1 fl oz) contains approximately 40 mg caffeine (Heckman et al., 
2010) and considering a mean body weight of 75 kg for males, individuals in the studies already 
mentioned were given a single caffeine dose equivalent to 11 cups of coffee. In contrast, the current study 
subjects using caffeine beverages were just moderate consumers (29% consumed 1 cup/day, 21% 2 
cups/day, 8% 3 cups/day, and only 6% consumed more than 3 cups/day). 
In conclusion, reference values for percent lymphocyte subsets in a population of nonfrail elderly 
individuals (65–95 years old) from Galicia (in northwestern Spain) were obtained. Our results illustrated 
how gender and age influence proportions of several peripheral blood lymphocyte subpopulations. No 
significant influence of the number of positive frailty items or of other lifestyle factors (smoking habits, 
physical activity, and alcohol and caffeine beverages consumption) was observed. The results obtained 
might serve as a basis to establish comparisons between frail and nonfrail elder individuals in future 
studies, in order to determine the usefulness of lymphocyte subsets as immunological biomarkers of 
frailty. 
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Notes 
a
Mean ± SD (range). 
b
Calculated according to Minnesota Leisure Time Activity (MLTA) questionnaire (Spanish validation by 
Ruiz Comellas et al., 2012). 
Note. SE: mean standard error. 
Note. CI: confidence interval, SE: mean standard error. 
Note. CI: confidence interval, SE: mean standard error. Means with different superscript letters represent 
significantly different groups: a ≠ b ≠ c, p < .05 (univariate statistics). Asterisk, significant at p < .05. 
Note. CI: confidence interval, SE: mean standard error. Asterisk indicates significant at p < .05. 
Note. CI: confidence interval, SE: mean standard error. 
Note. CI: confidence interval, SE: mean standard error. 
Note. CI: confidence interval, SE: mean standard error. 
Note. CI: confidence interval, SE: mean standard error. 
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